Syndax Pharma (SNDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -56,047 | -42,047 | -29,218 | -14,302 | -73,961 |
| Depreciation Amortization | -688 | -580 | -404 | -180 | -480 |
| Accounts payable and accrued liabilities | 4,739 | 5,193 | 838 | 2,908 | -792 |
| Other Working Capital | -241 | 34 | -2,663 | -3,941 | -302 |
| Other Operating Activity | 1,625 | -485 | 2,091 | -1,316 | 7,004 |
| Operating Cash Flow | $-50,612 | $-37,885 | $-29,356 | $-16,831 | $-68,531 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 12,781 | 6,185 | -6,179 | 12,752 | 51,585 |
| PPE Investments | N/A | N/A | N/A | N/A | -187 |
| Investing Cash Flow | $12,781 | $6,185 | $-6,179 | $12,752 | $51,398 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 28,570 | 28,512 | 28,432 | 28,428 | 15,721 |
| Other Financing Activity | 0 | 0 | 0 | -2 | 8 |
| Financing Cash Flow | $28,570 | $28,512 | $28,432 | $28,426 | $15,729 |
| Beginning Cash Position | 33,985 | 33,985 | 33,985 | 33,985 | 35,389 |
| End Cash Position | 24,724 | 30,797 | 26,882 | 58,332 | 33,985 |
| Net Cash Flow | $-9,261 | $-3,188 | $-7,103 | $24,347 | $-1,404 |
| Free Cash Flow | |||||
| Operating Cash Flow | -50,612 | -37,885 | -29,356 | -16,831 | -68,531 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -187 |
| Free Cash Flow | -50,612 | -37,885 | -29,356 | -16,831 | -68,718 |